World Literature on Medicinal Plants from Pankaj Oudhia’s Medicinal Plant Database -6

World Literature on Medicinal Plants from Pankaj Oudhia’s Medicinal Plant Database -6

World Literature on Medicinal Plants Quoted/Consulted/Modified/Improved/Discussed/Used/Corrected in Pankaj Oudhia’s Medicinal Plant Database.

For details please visit http://www.pankajoudhia.com

1. Jain, S.K. Studies in Indian Ethnobotany – less known uses  of fifty common plants from

tribal areas of Madhya Pradesh. Bull Bot Surv, India, 5: 225-236 (1963).

2. Jain, S.K wild food plants of tribals of Bastar (Madhya Pradesh). Proc Natl. Inst Sci., 30 B:

5-80 (1964).

3. Jain, S.K., On the prospect of some new and less known medicinal plants resources. Indian

Med. J., 59: 270 – 272 (1965).

4. Roy, G.P. and chaturvedi, K.K., Less known medicinal uses of rare and endangered plants of

Abujh Marh reserve area of Bastar (Madhya Pradesh) J. Econ. Tax Bot., 9: 325-328 (1987).

5. Chandra Umesh and Mehra, K.L., Ethnobotany of Abujh Marh: Medicinal plants used by

Abujimarhias in India, Asian conf. Trad. Asian Med (Abstract) 53 (1983).

6. Chopra, R.N., Nayar, S.L., and chopra, I.C., Glossary of Indian medicinal plants.

Publications and Information Directorate (CSIR), Hill side road, New Delhi India (1956).

7. Anonymous, The Wealth of India-Raw Materials series (Vol. I to XI, A- ) Publications and

Information Directorate (CSIR), Hillside Road, New Delhi, India (1946-1976).

1. Aho, K., Harmsen, P., Hatano, S., Marquardsen, J., Smirnov, V.E., Strasser, T.,

Cerebrovascular disease in the community: Results of a WHO collaborative study. Bull. WHO

1980: 58, 113-30.

2.  Kister, J.P., Ropper, A.A., Martin, J.B., Cerebrovascular disease:  Harrison’s Principles of

Internal Medicine, 1977-8, Vol. 2, 12th Ed. PP.

3.  Millkan, C.H., McDowell, F. and Easton, J.D. Stroke Lea and Febiger, Philadelphia, 1987:

71-77.

4. Wade, D.T., Hewet, R.L., Skilbeck, C.E. and  David, R.M. Stroke a critical approach to

diagnosis treatment and management. Chapman and Hall, London, 1985: 30-31.

5.  Wolf, P.A., Kannel, W.B. and Mc Gee, D.L. Epidemiology of strokes in North America. In:

Stroke - Pathophysiology, diagnosis and management (Vol. I) edited by Bernett, H.J.M.,;

Stein, B.M., Mohr, J.P. and Yatus, F.M., Churchill Livingstone, Inc. New York, 1986: 19-29.

6.  Kulkarni, S.K. and Verma Anitha: BR-16A (Mentat) - A herbal preparation improved learning

and memory performance in mice. Indian Drugs (30) 3 pp. 97-107.

7.  Quadri, A.A., Mentat in children with behavioural problems: Current Medical Practice, June

1993, pp. 121-5. 8.  Usha, P., Dave, Vijaysingh Chauvan and Jyoti Dalvi. Evaluation of BR-16A (Mentat) in

cognitive and behavioural dysfunction of mentally retarded children - A placebo controlled

study. Ind. J. of Pediatr. 1993: 60(3), 423-8.

9.  Palkar, S.A., Shah, L.P. Role of Mentat in ECT-induced Amnesia A preliminary study: The

Indian Practitioner, March 1993, pp. 225-98.

1. Hooker JD. Flora of British India. Vol. 3. London: Reeve and Co; 1882. p. 640.

2. Prasad S, Kashyap RS, Deopujari JY, Purohit HJ, Taori GM, Daginawala HF. Effect of Fagonia Arabica (Dhamasa) on in vitro thrombolysis. BMC Complement Altern Med. 2007;7:36. [PMC free article] [PubMed]

3. Mucklow JC. Thrombolytic treatment – streptokinase is more economical than Alteplase. BMJ. 1995;311:1506. [PMC free article] [PubMed]

4. Collen D. Coronary thrombolysis: streptokinase or recombinant tissue-type plasminogen activator? Ann Intern Med. 1990;112:529–38. [PubMed]

5. Rouf SA, Moo-Young M, Chisti Y. Tissue-type plasminogen activator: characteristics, applications and production technology. Biotechnol Adv. 1996;14:239–66. [PubMed]

6. Demrow HS, Slane PR, Folts JD. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation. 1995;91:1182–8. [PubMed]

7. Briggs WH, Folts JD, Osman HE, Goldman IL. Administration of raw onion inhibits platelet-mediated thrombosis in dogs. J Nutr. 2001;131:2619–22. [PubMed]

8. Leta GC, Mourão PA, Tovar AM. Human venous and arterial glycosaminoglycans have similar affinity for plasma low-density lipoproteins. Biochim Biophys Acta. 2002;1586:243–53. [PubMed]

9. Li Z, Wang H, Li J, Zhang G, Gao C. Basic and clinical study on the antithrombotic mechanism of glycosaaminoglycan extracted from sea cucumber. Chin Med J (Engl) 2000;113:706–711. [PubMed]

10. Rajapakse N, Jung WK, Mendis E, Moon SH, Kim SK. A novel anticoagulant purified from fish protein hydrolysate inhibits factor XIIa and platelet aggregation. Life Sci. 2005;76:2607–19. [PubMed]

Abdel-Ghaffar, F. and Semmler, M.  (2007)  Efficacy of neem seed extract shampoo on head

lice of naturally infected human in Egypt.  Parasitol. Res. 100: 329–332.

Baily, A. M.,  Prociv, P. (2000)  Persistent head lice following multiple treatments : evidence or

insecticide resistance in Pediculus humanus capitis.  Australas J. Dermatal 41: 250–254.

Burkhart, C. G.  (2004)  Relationship of treatment resistant head lice to the safety and efficacy

of pediculicides.  Mayo Chlin. Proc. 79: 661–666.

Pollack, R.J., Kijzewski, A., Armstrong, P., Hahn, C. Wolfe, N., Rahman, H.A. (1999).   Differentia

permethrin susceptibility of head lice sample in US and Borneo. Arch. Pediatr. Adolese. Med.

153: 969–973.

Rassami, W. and Soonwera, M.  (2009)  Some effect from medicinal plant for controlling human

head louse : Case study on Wat Ratchakosa school, Ladkrabang, Bangkok. p364–369 in

Rambhai Barni Rahabhat University Conference, Chanthaburi, Dec, 20 –21, 2009.

Soonwera, M.  (2005).   Efficacy of zingiberaceae plant extracts an zingiberaceae shampoo for

controlling head lice. King Mongkut’s Agricultural Journal. 23: 52–57.

Soonweera, M. and W. Wangspha . (2007).  Effectiveness of Botanical shampoo to control human

head louse : case study on school girls at Wat-Podsattha school and Wat- Sutthaod school, 

p331 – 334 in International conference on Integration of science & Technology for sustainable

development, KMITL, Bangkok, April, 26–27,  2007.

Suppasan, S.  (2005).  Control of human head louse (Pediculus capitis De Geer.) by some medicinal

plant extracts.  Master of Science in Plant Pest Management Technology Thesis,  King

Mongkut’s Institute of Technology Ladkrabang, Bangkok.

Wikipedia.  (2009).  Head louse. [Online]. Available : http://en.wikipedia.org. (20/09/2009)

1. Apte, V.S The pratical Sanskrit – English Dictionary revised Edicition 1965.

2. Chunakar, K.C. Bhava prakash nighantu (Indian Materia medica of sri bhava misra (1500-

1600 A.D)., Hindi comentry, Chaukambha Bharati academy, Varanasi 1984.

3. Dhyani, S.C. Nidana Cikitsa (Gujarati), University Book production board (Gujarat state) –

Ahmedabad, 1977.

4. Jadavji, T.A The CARAKA SAMHITA OF AGNIVESA, Munshiram manoharlal publishers

private limited, New Delhi 1981.

5. Monir M.W A Sanskrit – English Dictionary, Marwah Publications, New Delhi, 1986.

6. Nadakarni, A.K Dr. K.M Nadakarni’s Indian material medica Vol II, Popular prakasham

private limited, Bombay, 1976.

7. Sastri, S. Madhavanidanam of MADHAVA (Hindi comentry) Vol II, Chaukamba Sanskrit

series office, Varanasi, 1973.

[1] Kalia, AN, ”Textbook of Industrial Pharmacognosy”,  First Edition, C. B. S. Publication,

2009, p.97. 

[2] Evans T, ”Pharmacognosy”, Thirteenth Edition, Bailliere Tindall Publication, london, 1994,

p.69.

[3] Kokate, CK, Purohit, A P And Gokhale, SB, ”Pharmacognosy”,Twenty Nine Edition, Nirali

Prakashan, 2004, p.72. 

[4] Chopra, R N, Nayer, S L, and Chopra, I C, “Glossary of Indian Medicinal Plants”, CSRI,

New Delhi 1992, p.32.

[5] Chatterjee, N, Rastogi, R P and Dhar ML, Indian J. Chem., 1965, 3, 24

[6] Basu N., Rastogi R P and Dhar M , Indian J. Chem., 1967, 5, 84.

[7] Chatterjee N, Rastogi R P, and Dhar, M L, Indian J. Chem., 1963, 1, 212.

[8] Sastry MS, Dhalla N S and Malhotra CL, Indian J. Pharma., 1959, 21, 303.

[9] Proliac A, Chabaud A and Raynaud  J. Pharm. Acta. Helv., 1991, 66 153.

[10] Schulte KE, Rucker G and Etkersch M, Phytochemistry, 1972,11, 2649 

[11] Anonymous, “Indian Medicinal Plants” (A compendium  of 500 species) Vol-1, Orient

Longman Ltd. 1997, p. 84.

[12] Handa, SS Pharma Times, 1994, 26 (3), 17.

[13] Singh RH Singh L., J. Res. Ayur. Siddha, 1980,1 (1) ,133.

[14] Jayaram S, Walwaikar, PP Rajadhyaksha, S.S., Indian Drugs 1993, 30 (10), 498.

[15] Harborne JB: Phytochemical methods, Third Edition, Chapman and Hall, London, 1988, p

117.

[16] Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a

standardized single disk method. Am. J. Clin. Path. 1966, 45, 493.

1. Stewart RR. Flora of West Pakistan. Fakhri printing press, Karachi. 1972:646. 

2. Nadkarni KM. Indian Materia Medica.  Popular Prakashan Private, Bombay.

1976:624–625. 

3. Anonymous. The wealth of India: Raw materials, Council of scientific and

industrial research, New Delhi 1988, 2:2–3. 

4. Mathew J, Paul J. Nandhu MS, Paulose CS. Bacopa monnieri and Bacoside - A

for ameliorating epilepsy associated behavioral deficits. Fitoterapia 2010; 81:315-

22.  

5. Salil KB, Ashok K, Shibnath G. Effect of  Bacopa monniera on animals models

of Alzheimer’s disease and perturbed central cholinergic markers. Molecular

Aspects of Asian Medicine 2001; 1:21-32. 

6. Roodenrys S, Booth D, Bulzomi S,  et al. Chronic effects of Brahmi (Bacopa

monnieri) on human memory. Neuropsychopharmacology 2002; 27:279-281. 

7. Channa S, Dar A, Anjum S, Yaqoob M. Atta-ur Rahman. Anti-inflammatory

activity of  Bacopa monniera in rodents. Journal of Ethnopharmacology 2006;

104:286–289.  

8. Tripathi YB, Chaurasia S, Tripathi E, Upadhyay A, Dubey GP.  Bacopa

monneira as an antioxidant: mechanism of action. Indian Journal of  Experimental

Biology 1996; 34:523-526. 

9. Chowdhuri DK, Parmar D, Kakkar P, et  al.  Antistress effects of bacosides of

Bacopa monniera: modulation Hsp70 expression, Superoxide dismutase and

cytochrome P450 activity in rat brain. Phytotherapy Research 2002; 16:639-645. 

10. Salil KB, Ghosal S. Anxiolytic activity of a standardized extract of  Bacopa

monniera: an experimental study. Phytomedicine 1998; 5:77-82. 

11. Sairam K, Dorababu M, Goel RK, Bhattacharya SK. Antidepressant activity of

standardized extract of Bacopa monniera in experimental models of depression in

rats. Phytomedicine 2002; 9:207-211. 

12. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database

of Systematic Reviews Issue 4. Art. No.: CD005454. DOI:10.1002/14651858.

CD00 5454.pub2. 2007

13. Gray AM, Pache DM, Sewell RDE. Do α2-adrenoceptors play an integral role in

the antinociceptive mechanism of action  of antidepressant compounds? European

Journal of Pharmacology. 1999a; 378: 161-168. 

14. Eaton M. Common animal models for spasticity and pain. Journal of 

Rehabilitation Research and  Development 2003; 40:41-54.

15. Gray AM, Spencer PSJ, Sewell RDE. The involvement of the opioidergic system in

the antinociceptive mechanism of action of antidepressant compounds. British Journal

of Pharmacology 1998; 124:669-674. 

16. Gray AM, Nevinson MJ, Sewell RDE.  The involvement of opioidergic and

noradrenergic mechanisms in nefopam  antinociception. European Journal of

Pharmacology. 1999b; 365:149-157. 

17. Brochet D, Micό J-A, Martin P, Simon P. Antinociceptive activity of betaadrenoceptor agonists in the hot plate test in mice. Psychopharmacology 1986; 88:527-

528. 

18. Grillet N, Pattyn A, Contet C, et  al. Generation and characterization of Rgs4

mutant mice. Molecular and Cellular Biology 2005; 25:4221–4228. 

19. Berkenkopf JW, Weichmann BM. Production of prostaglandin in mice

following intraperitoneal injection of acetic acid, phenyl benzoquinone and

zymosan: Its role in the writhing response. Prostaglandins 1988; 36:693-709. 

20. Matsumoto H, Naraba H, Ueno A,  et al. Induction of cycloxygenase-2 causes

an enhancement of writhing response in mice. European Journal of Pharmacology

1998; 352:47-52. 

21. Ballou LR, Botting RM, Goorha S, Zhang J, Vane JR. Nociception in

cyclooxygenase isozyme-deficient mice. Proceedings of  National  Academy of

Science 2000; 97:10272-10276. 

22. Bentley GA, Newton SH, Starr J. Evidence for an action of morphine and

enkephalins on sensory nerves endings in the mouse peritoneum.  British Journal of

Pharmacology 1981; 73:325-332.  

23. Bentley GA, Newton SH, Starr J. Studies on the  antinociceptive action of α-

agonist drugs and their interaction with opioid mechanisms. British Journal of

Pharmacology 1983; 73:125-134. 

24. Chan TF, Tsai HY, Tian-Shang W. Anti-inflammatory and analgesic activities

from the roots of Angelica pubescens. Planta Medica 1995; 61:2-8. 

25. Hammond DL. Inference of pain and its modulation from simple behaviors. In:

Chapaman C.R., Loeser, J.D., eds. Issues  in pain management: advances in pain

research and therapy. Raven Press, New York. 1989:69–91.

26. Tjølsen A, Lund A, Hole K.  Antinociceptive effect of paracetamol in rats is

partly dependent on spinal serotonergic systems. European Journal of

Pharmacology 1991; 193:193–201. 

27. Pini LA, Vitale G, Ottani A, Sandrini  M. Naloxone-reversible antinociception

by paracetamol in the rat. Journal of Pharmacology and Experimental Therapeutics

1997; 280:934-940. 

28. Hosseinzadeh H, Younesi HM. Antinociceptive and anti-inflammatory effects

of Crocus sativus stigma and petal extracts in mice. BioMed Central Pharmacology

2002; 2:7. 

29. Vohora SB, Khanna T, Athar M, Ahmad B. Analgesic activity of bacosine, a

new triterpene isolated from Bacopa monniera Fitoterapia. 1997; 4:361-365. 

30. Stephens R J. Evidence for a pharmacokinetic interaction between ibuprofen

and meptazinol in the mouse. Journal of  Pharmacology and  Experimental

Therapeutics 1984; 36:779-781. 

31. Bjorrkman R, Hedner J, Hedner T,  Henning M. Central, naloxone-reversible

antinociception by diclofenac in the rat. Naunyn-Schmiedeberg's Archives of

Pharmacology 1990; 342:171-176. 

32. Sumathi T, Nayeem M, Balakrishna K, Veluchamy G, Devaraj SN. Alcoholic

extract of ‘Bacopa monniera’ reduces the in vitro effects of morphine withdrawal in

guinea-pig ileum. Journal of Ethnopharmacology 2002; 82:75-81. 

Ahmed  F.  and  Urooj  A.  (2010)  :  Anticholinesterase

activities  of  cold  and  hot  aqueous  extracts  of  F.

racemosa stem bark. Phcog Mag. 6:142-144.

Alvarez  A.  and  Inestrosa  N.C.  (2005)  :  Acetylcholinesterase  in  Alzheimer's  disease  :  Its  molecular

interactions with the amyloid bpeptide : In Recent

trends  in  Acetylcholinesterase  system  (Eds)  M.

Parveen  and  S.  Kumar  (Amesterdom,  Berlin,

Oxford, Washington D.C., IOS Press) pp 11-22.

Bonesi M., Menichini F., Tundis R., Loizzo M.R., Conforti

F., Passalacqua N.G., Statti G.A. and Menichini F.

( 2 0 1 0 ) : A c e t y l c h o l i n e st e r a s e a n d

butyrylcholinesterase  inhibitory  activity  of  Pinus

species essential oils and their constituents. Journal

of  Enzyme  Inhibition  and  Medicinal  Chemistry.

[Epub ahead of print].

Das A., Shanker G., Nath C., Pal R., Singh S. and Singh

H.K. (2002)  : A comparative study  in rodents  of

standardized  extracts  of  Bacopa  monniera and

Ginkgo  Biloba.  Pharmacology,  Biochemistry  and

Behavior, 73, 893-900.

De Sarno P., Pomponi M, Giacobini E., Tang X.C.  and

Williams  E. (1989) :  The  effect  of heptylphysostigmine,  a  new  cholinesterase  inhibitor,  on

the central cholinergic system of the rat.

Neurochemical  research, 14 (10); 971-7.

Ellman  G.  L.,  Courtney K.D.,  Andres  V.  Jr.  and

Featherstone  R.M.  (1961)  :  A new  and  rapid

colorimetric  determination  of  acetylcholinesterase

activity. Biochem. Pharmacol. 7, 88–95.

Enz  A.,  Amstutz  R.,  Boddeke  H.,  Gmelin  G.  and

Malanowski J. (1993) : Brain selective inhibition of

acetylcholinesterase : a novel approach to therapy

for Alzheimer’s disease. Prog Brain Res. 98; 431-38.

Hacibekiroqlu, Kolak U. (2011) : Anticholinesterase plant

extract. Phytother Res. 25 (4):522-529.

Heinrich M.  and Teoh H.L. (2004)  : Galantamine from

snowdropthe development of a modern drug against

Alzheimer’s disease from local Caucasian

knowledge. J Ethnopharmacol. 92 (2-3); 147-62.

Ingkaninan K., Temkitthawon P., Chuenchom K., Yuyaem

T.  and  Thongnoi  W.  (2003)  :  Screening  for

acetylcholinesterase  inhibitory  activity  in  plants

used in Thai traditional rejuvenating and neurotonic

remedies . Journal of Ethnopharmacology, 89 (2-3);

261-264.

Kumar N.S., Mukherjee P.K., Bhadra S., Saha B.P. and Pal

B.C. (2010) : Acetylcholinesterase inhibitory

potential  of  a  carbazole  alkaloid,  mahanimbine,

from Murraya koenigii. Phytotherapy Research, 24

(4); 629-31.

Liu J., Olivier K.  and Pope C.N. (1999) : Comparative

neurochemical effects of repeated methyl parathion

or chlorpyrifos exposures in neonatal and adult rats.

Toxicology of Applied Pharmacology, 158,

186–196.

López S., Bastida J., Viladomat F. and Codina C. (2002) :

Acetylcholinesterase  inhibitory  activity  of  some

Amaryllidaceae  alkaloids  and  Narcissus  extracts,

Life Sciences, 71(21); 2521-2529.

Lowry O.H., Rosebrough N.J., Farr A.L. and Randall R.J.

(1951) : Protein measurement with the Folin phenol

reagent. J. Biol. Chem. 193, 265–275.

Mukherjee  P.K.,  Kumar  V.  and  Houghton  P.J.  (2007)  :

Screening of Indian medicinal plants for

acetylcholinesterase inhibitory activity.

Phytotherapy Research,   21 (12), 1142-1145.

Orhan  B.  Sener  (2009)  :  Sustainable  use  of  various

amaryllidaceous plants against Alzheimer’s

disease. ISHS Acta Horticulture 4, 678.

Orhan  B.  and  Aslam  (2009)  :  Appraisal  of  scolamineinduced  antimnesic  effect  in  mice  and  in  vitro

anticholinesterase and antioxidant activities of some

traditionally used Lamiacae plants. J. of

Ethanopharmacology, Vol. 122 (2) 327-332.

Pal R. and Sarin J.P.S. (1992) : Quantitative determination

of  bacosides  by  UV-spectrophotometry.  Ind  J

Pharmacol Sci. 54 : 17-8.

Racchi  M.,  Mazzuchelli  M.,  Porrello  E.,  Lanni  C.  and

Govoni S. (2004) : Acetylcholinesterase inhibitions:

novel activities of old molecules. Pharmacological

Research 50 : 441-451.

Rønsted N., Savolainen V., Mølgaard P.  and Jäger A.K.

(2008) : Phylogenetic selection of Narcissus species

for  drug  discovery.  Biochemical  Systematics  and

Ecology 36; 417-22.

Schulz  V.  (2003)  :  Ginkgo  extract  or  cholinesterase

inhibitors in patients with dementia; what clinical

trial and guidelines fail to consider. Phytomedicine

10 (Supplementary 4): 74-79.

Suganthy  N.,  Pandian  S.K.  and  Devi  KP.  (2009)  :

Cholinesterase  inhibitory  effects  of  Rhizophora

lamarckii, Avicennia officinalis, Sesuvium

portulacastrum  and  Suaeda  monica;  Mangroves

inhabiting an Indian coastal area (Vellar Estuary),

Journal  of Enzyme Inhibition and  Medicinal

Chemistry, 24 (3); 702-707.

Tonduli L.S., Testylier G., Masqueliez C., Lallement G.

and Monmaur P. (2000) : Effect of huperzine used as

pre-treatment against soman-induced seizures.

Neurotoxicology. 15, 1-9. Toxicology. 34, 84 -90.

Whitehouse P.J.  (1993) : Cholinergic therapy in dementia.

Acta Neurologica Scandmavica 88 (149): 42-45.

Zeman W. and Innes J.R.M. (1963) : Craigie’s

Neuroanatomy of  the  Rat, pp.  21-25.  Academic

Press, New York,

1. Kumpulainen, J. T.; Salonen, J. T. (1999): Natural antioxidants 

and anticarcinogens in Nutrition, Health and Disease, The Royal

Society of Chemistry, UK, pp.178-187.

2. Cook, N.C.; Samman, S. (1996): Flavonoids-chemistry,

metabolism, cardio protective effects and dietary sources, Nutri

Biochem, 7, 66-76.

3. Brussels, (2001): Third United Nations Conference on the least

developed countries profile, Medicinal Plants, 2.

4. Kikuzaki, H. and Nakatani, N. (1993): An effect of some ginger

constituents, J Food Chem, 57, 2144 -2155.

5. Diolock, A.T.; Charleux, J.L. ; Crozier-Willi, G.; Kok, F.J.; RiceEvans, C.; Roberfroid, M.; Stahl, W.; Vina-Ribes, J.B.R.. (1998):

J.Nutr, 80, S77-S112.

6. Saito, M.; Sakagami, H.; Fujisawa, S. (2003): Cytotoxicity and

apoptosis induction by butylated hydroxyl anisole (BHA) and

butylated hydroxytoluene (BHT), Anticancer Res, 23, 4693-

4701.

7. Stefanidou, M.; Alevisopouls, G.; Chatziioannou, A. (2003):

Vet.Hum.Toxicol, 45, 103-105

8. Chen, H.M.; Muramoto, K.; Yamavchi, F.S. and Nokihara,

K.(1996): Antioxidant activity of design peptides based on

antioxidative peptide isolated form digest of a soybean protein,

J Agric Food Chem, 44, 2619-2623

9. Halliwell, B. and Gutterridge, J.M.C. (1993): Free Radicals in

Biology and Medicine, Oxford, Clarendon, 419.

10. Kiritikar, K.R. and Basu, B.D. (1988): Indian medicinal plants,

Allahabad, 2639.

11. 11.Sharma, P.C.; Yelne, M.B. and Dennis, T.J. (2001): Database

on medicinal plants used in Ayurveda, Delhi, Documentation

and Publication Division, Central Council for Research in

Ayurveda and Siddha, Vol (3), 404.

12. Gupta, M.B.; Palik, T.K.; Sing, N. and Bhargava, K.P. (1971):

Indian J Med Res, 59, 76.

13. Radha; Shanmuga Sundharam, K.; Ramanujam, S. and

Shanmuga Sundaram E.R.B. (1994): J Ethnopharmacol, 42, 88.

14. Komai, K. and Ueki. (1975): Weed Res, 20, 66

15. Sing, P.N. and Sing, S.B. (1980): Phytochemistry, 19, 2056. 

16. Sing, S.B. and Sing, P.N. (1986): J Indian Chem Soc, 63, 450.

17. Jose Lapenta, R. (2000): Dermagic / Express 2.2000, 97,

http://www.dermagic.i8.com/year2000/cyperus.html.

18. Ohira, S.; Hasegawa, T.; Hayasahi, K.I.; Hoshino, T.; Takaoka, D.

and Nozaki, H. (1998): Phytochemistry, 47, 577.

19. Mekem Sonwa, M. and Konig, W.A. (2001): Phytochemistry, 58,

799.

20. Anonymous.Indian herbal pharmacopoeia. vol 1, IDMA,

Mumbai (1998) 30-37

21. 21.Kirtikar KR and Basu BD. Indian Medicinal plants. VOl I,

Bishen Singh Mahendrapal Singh, Dehradun (1994) 1816-1817

22. Kokate CK, Purohit Ap, Gokhale Sb, Pharmacognosy, 3rd

edition, Nirali Prakashan, Pune; 1995

23. Khandelwal KR (2006). Practical Pharmacognosy. Nirali

Prakashan,  Pune, India. 149

24. Singleton VL, Rosi JA, Am. J. Enol. Vitic 1965; 10: 144-158

25. J. Zhishen, T.Mengcheng, W.Jianming, Food Chemistry, 64,

1999, 555-559.

26. Oyaizu M. studies on products of browning reaction.

Antioxidant activities of products of browning reaction

prepared from glucosamine. Jpn J Nutr 1986; 44: 307-315.

27. Ruch RJ, cheng SJ, Klaunig JE , Carcinogenesis 1989;  10: 1003-

1008

28. Garrat D C, the Quantitative Analysis of Drugs, Japan, Chapman

and Hall, 1964, 456

29. Elizabeth K, Rao MNA (1990) Oxygen radical scavenging activity

of curcumin. Inter J Pharm 58:237–240

30. Patra J, Rath S, Karmabeer J. Evaluation of antioxidant and

antimicrobial activity of seaweed ( Sargassun sp. ) Extract : A

study on inhibition of glucathione-s transferase activity. Turk J

Biol 2008; 32: 119-125

1. ChatteIjee N., RastogiR.P.and.Dhar M.L.: Examination of Bacopa monniera wertst, PartI, Isolation of Chemical Compound, Indian J Chern, Vol. 1, p 212-215, 1963.

2. Bhakuni D.S., Dhar M.L., Dhar M.M., Dhawan RN. and Mehrotra B,N.: Screening of

Indian Plants for biological Activity Part II, Indian Journal of Experimental Biology,

Vol.7, p 250-262, 1969.

3. Singh H.K., Dhawan B.N.: Effect of Bacopa monnieri Extract on Avoidance Responses

in Rat, J Ethnopharmacol 5:2, p 205-214, 1987.

4. Sahu T.R.: Less Known Uses of Weeds as Medicinal Plant, Ancient Sci life, 34, 0245-

249, 1984.

5. Naqvi, SoAH., Khan MoS.Y., Vohara SoB.: Antibacterial, Antifungal and Anthelmintic

Investigation on Indian Medicinal Plants, Fitoterapia, 62 (3), P 221-228, 1991.

6. Kakrani H.N., Sluja A.K: Traidtional Treatments through Herbs in Kutch district, Gujarat

State, India, Part n, Analgesic, Antiinflmmatory, Antirheumatic Antiarthritic Plants,

Fitoterapi~ Vol. LXV, N05, p427-430, 1994.

7. Kokate C.K, Purohit AP., Gokhale S.B.: Pharmacognosy, 6ili Edition, Nirali Prakashan,

Pune, p 113-134,.1997.

8. Kulkarni S.K: Handbook of Experimental Pharmacology, 3rd Edition, Vallabh

Prakashan, p 37-80, 1999.

9. Banerjee S.K., Chakravarthi R.N.: Haemolytic Activity of Bacoside A and B, Bull

Calcutta SCH Troop Med, 112, p 57-58, 1963.

10. Tripathi YB, Chaurasia S., Tripathi E., Upadhyay A., Dubey G.P.: Bacopa monniri linn.

as an Antioxidant: Mechanism of Action, Indian J Expt BioI, 34:6, p 523-526, 1996.

11. Tripathi J.S., Singh H.K.: Clinical Evaluation of Smrithiragarasa in case of Recidual

Schizophrenia, Journal of Research in Ayurveda and Siddh~ Vol. IS (1-2), p 107, 1994.

12. Gupta B.S., Gupta u., Dixit S.P., Dubey G.P.: Brahmi Slows Down the Memory loss in

Aged Rats (A-21), International Seminar -on Free Radical Mediated Disease and

Ayurveda, Faculty of Ayurveda, IMS, BOO, Varanasi,India. 2-4 Sep 1996.

13. Sharma R., Chaturvedi C., Tewari P.v.: Efficacy of  Bacopa monnieri  in Revitalizing

Intellectual Function in Children, J Res Edu Ind Med. 61:2, p 1-10, 1984.

14. Garai S., Mahato S.B., Othani K, Yamasaki K: Dammarane Type Triterpenoid Saponins

from Bacopa monnieri, Phytochemistry, Vo1.42 (3), p 815-820, 1996.

15. Wu F, Zau Z.: Recent Progress in Saponin Chemsitry, Youji Huaxue, 60 (6), P 409-415,

1986.

1. Sivaramakrishna C, Chirravuri V R, Trimurtulu G, Vanisree M,

Gottumukkala V, Subbaraju:. Triterpenoid glycosides from  Bacopa

monnieri. Phytochemistry 2005; 66: 2719–2728.

2. Jain P, Khanna N K, Trehan T, Pendse V K,  Godhwani J L: Antiinflammatory effects of an Ayurvedic preparation, Brahmi Rasayan

in rodents. Indian J. Exp. Biol. 1994; 32: 633–636.

3. Chatterji N, Rastogi R P and Dhar M L: Chemical examination of

Bacopa monnieri Wettst.  Parti-isolation of chemical constituents.

Indian J. Chem.1965; 3:24–29.

4. Rastogi S, Pal R and Kulshreshtha D K: Bacoside A3-a triterpenoid

saponin from Bacopa monnieri. Phytochemistry 1994; 36: 133–137.

5. Sastri M S, Dhalla N S. and Malhotra C L: Chemical investigation of

Herpestis monniera  Linn (Brahmi).  Indian J. Pharmacol 1959; 21:

303–304.

6. Ramawat K G, Merillon J M: Biotechnology: secondary metabolites.

Oxford & IBH Publishing Co. PVT.LTD New Delhi, 1999: 199.

7. Vanisree M, Lee C Y, Lo S F, Nalawade S M, Lin C Y, Tsay H S: Studies

on the production of some important secondary metabolites from

medicinal plants by plant tissue culture. Bot. Bull. Acad. Sin 2004; 45:

1-22.

8. Chang Ho Park, Blanca C. and Martinez: Enhanced release of

rosmarinic acid from  Coleus blumei permeabilized by dimethyl

sulfoxide (DMSO) while preserving cell viability and growth.

Biotechnology and Bioengineering 2004; 40:459-464.

9. Sharth R, Krishna V, Sathyanarayanab B. N, Harish B G: Antibacterial

activity of Bacoside-A- an active constituent isolated of  Bacopa

monneiri (L.). Wettest.Pharmacologyonline 2008; 2: 517-528.

10. Brodelius P: Permeabilization of plant cells for release of

intracellularly stored products: viability studies.   Applied Microbiol

Biotechno.1988; 27: 561-566.

11. Gabriela T T, Jonathan C C, Guadalupe S M, Jose Luis T E, Martha L,

Arenas O, Antonio J A:  Beta vulgaris L. Suspension cultures

permeabilized with  Triton X-100 retain cell viability and

Betacyanines Production Ability: A Digital Image Analysis Study.

Biotechnol Prog. 2007; 23: 359-363.

12. Mendhulkar V D and Moinuddin M Ali: Saponin Estimation in Vigna

radiata Cell Culture Treated with Cell Permeabilizing Agent, Triton X

-100. Advances in Plant Sciences India 2009; 22: 1-5.

Aasim, M., Khawar, K. M.,  and S. Özcan (2010). Efficient  in

vitro  propagation from pre-conditioned embryonic axes

of Turkish cowpea (Vigna unguiculata L.) cultivar akkiz.

Arch. Biol. Sci. 62, 1047-1052.

Aasim, M., Day, S., Rezai, F., Hajyzadeh, M., Mahmud, S. T. and

S. Ozcan  (2011).  In vitro  shoot regeneration from preconditioned explants of chickpea (Cicer arietinum L.) cv.

Gokce. Afr. J. Biotech. 10, 2020-2023.

Aasim, M. (2012). Micropropagation of lentil (Lens culinaris

Medik.) using pulse treatment of immature plumular apices.  Pak. J. Agri. Sci. 49, 149-154.

Ali, G., Srivastava, P. S., and M. Iqbal (1999). Morphogenic and

biochemical responses of Bacopa monnieri cultures to zinc

toxicity. Plant Sci. 143, 187-193.

Anbarsi, K., Vani, G., Balakrishna, K., and Devi, C. S. (2006). Effect of bacoside A on brain antioxidant status in cigarette

smoke exposed rats. Life Sci. 78, 1378-1384.

Basu, N., and Walia, K., (1994). The chemical investigations of

the leaves of Herpestis monniera. Indian J. Pharm. 4, 84-

85.

Ceasar S. A., Maxwell S .L., Prasad K. B., Karthigan M., and S.

Ignacimuthu (2010). Highly efficient shoot regeneration of

Bacopa monnieri (L.) using a two-stage culture procedure

and assessment of genetic integrity of micropropagated

plants by RAPD. Acta Physiol. Plant. 32, 443-452.

Celiktas, N., Can, E., Hatipoglu, R., and S. Avci (2006). Somatic

embryogenesis, callus production, and plantlet growth in

sainfoin (Onobrychis viciifolia Scop.) New Zealand J. Agric.

Res. 49, 383-388.

Chatterji, N., R. P. Rastogi and M. L. Dhar  (1963). Chemical examination of Bacopa monnieri Westtst. Part I-isolation of

chemical constituents. Indian J. Chem. 1, 212-215.

Chatterji, N., Rastogi R. P,. and M. L. Dhar (1965). Chemical examination of Bacopa monnieri Westtst.: Part II-the constitution of bacoside A. Indian J. Chem. 3, 24-29.

Chopra, R. N. (1958). Indigenous Drugs of India. 2nd ed. Calcutta, India: U.N. Dhur and Sons; pp341.

Mukherjee, D. G. and C. D. Dey  (1996). Clinical trial on Brahmi.

I. J. Exper. Med. Sci. 10, 5-11.

Sancak, C., Mirici, S., and S. Özcan (2000). High frequency shoot

regeneration from immature embryo explants of Hungarian vetch. Plant Cell Tiss. Org. Cult. 61, 231-235.

Özcan, S., Yıldız, M., Sancak, C., and M. Özgen (1996). Adventitious shoot regeneration in sainfoin (Onobrychis viciifolia

Scop). Tur. J. Bot. 20, 497-501.

Özgen, M,, Özcan, S., Sevimay, C. S., and C. Sancak (1998). High

frequency adventitious shoot regeneration in sainfoin.

Plant Cell, Tiss. Org. Cult. 52, 205-208.

Shakoor, A., Akram, M., Asharaf, C. M.,  and M. R. Siddiqui

(1994). Pharmagonistic study and chemical / pharmacological evaluation of Brahmi-buti. Hamdard Medicus. 37,

92-109.

Sharma, S., Kamal, B., Rathi, N., Chauhan, S., Jadon, V., Vats

N., Gehlot, A., and S. Arya (2010). In vitro rapid and mass

multiplication of highly valuable medicinal plant Bacopa

monnieri (L.) Wettst. African J. Biotech. 9, 8318-8322.

Snedecor, G. W., and W. G. Cochran (1967). Statistical Methods.

The Iowa State University Press, Iowa, USA.

Stough, C., Lloyd, J., Clarke, J., Downey, L., Hutchinson, C., Rodgess, T., and P. Nathan (2001). The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function

in healthy human subjects. Psychopharacol. 156, 481-484.

Tiwari, V., Tiwari, K. N., and B. D. Singh (2001). Comparative

studies of cytokinins on in vitro propagation of  Bacopa

monniera. Plant Cell Tiss. Org. Cult. 66, 9-16.

Vijayakumar, M., Vijayakumar R., and R. Stephen (2010). In vitro

propagation of Bacopa monnieri L.-a multipurpose plant.

Indian J. Sci. Tech. 3, 781-786.

Vohora, S. B., Khanna, T., and M. Athar (1997). Analgesic of activity of Bacoside a new triterpene isolated from Bacopa

monniera. Fitoterapia, 68, 161-365.

Abell F, Krams M, Ashburner J, Passingham R, Friston K, Frackowiak R, Happé F,

Frith  C, Frith U. (1999). The neuroanatomy of autism: A voxel-based whole

brain analysis of structural scans. Neuroreport, 10: 1647-1651.

Acharya MM, Hattiangady B, Shetty AK. (2008). Progress in neuroprotective

strategies for preventing epilepsy. Progress in Neurobiology, 84: 363-404.

Adler CM, Goldberg TE, Malhotra AK, Pickar D, Breier A. (1998). Effects of

ketamine on thought disorder, working memory, and semantic memory in

healthy volunteers. Biol Psychiatry, 43: 811-816.

Aithal HN, Sirsi M. (1961). Pharmacological investigation on  Herpestis monniera.

Indian J. Pharmacol., 23: 2-5.

Alam AM, Starr MS. (1993a). Dopaminergic modulation of pilocarpine-induced

motor seizures in the rat: the role of hippocampal D2 receptors. Neuroscience,

53: 425-431.

Alam AM, Starr MS. Bimodal. (1994a). Effects of dopamine D2 receptor agonists on

zero Mg2+ -induced epileptiform activity in the rat cingulate cortex slice. Exp.

Brain. Res., 102: 75-83.

Aldridge JE, Meyer A, Seidler FJ, Slotkin TA. (2005). Alterations in Central Nervous

System Serotonergic and Dopaminergic  Synaptic Activity in Adulthood after

Prenatal or Neonatal Chlorpyrifos Exposure.  Environ. Health Perspect., 113:

1027-1031.

Allen G, Buxton RB, Wong EC, Courchesne E. (1997). Attentional activation of the

cerebellum independent of motor involvement. Science, 275: 1940-1943.

Alonso A, Garcia-Austt E. (1987). Neuronal sources of theta rhythm in the entorhinal

cortex of the rat. II. Phase relations  between unit discharges and theta field

potentials. Exp. Brain Res., 67: 502-509.

Alonso A, Köhler C. (1984). A study of the reciprocal connections between the

septum and the entorhinal area using anterograde and retrograde axonal

transport methods in the rat brain. J. Comp. Neurol., 225: 327-343.

Altman HJ, Normile HJ, Galloway MP, Ramirez A, Azmita EC. (1990). Enhanced

spatial discrimination learning. In rats following 5, 7, DHT- induced

serotonergic deafferation of the hippocampus. Brain Research, 518: 61-66.

Alves SH, Pinheiro G, Motta V, Landeira-Fernandez J, Cruz APM. (2004).

Anxiogenic effects in the rat elevated plus-maze of 5-HT2C agonists into ventral

but not dorsal hippocampus. Behav. Pharmacol., 15: 37-43.

Amaducci L, Forno KI, Eng LF. (1981). Glial fibrillary acidic protein in cryogenic

lesions of the rat brain. Neuroscience Lett., 21: 27-32.

Amaral DG, Insausti R, Cowan WM. (1983). Evidence for a direct projection from the

superior temporal gyrus to the entorhinal cortex in the monkey. Brain Res., 275:

263-277.

Amaral DG, Witter MP. (1989). The three dimensional organization of the

hippocampal formation: a review of the anatomical data. Neuroscience, 31: 571-

591.

Amit DJ, Brunel N, Tsodyks MV. (1994).  Correlations of cortical Hebbian

reverberations: theory versus experiment. J. Neurosci., 14: 6435-6445.

Applegate CD, Tecott LH. (1998). Global increases in seizure susceptibility in mice

lacking 5-HT2C receptors: A behavioural analysis. Exp. Neurol., 154: 522-530.

Arnold PS, Racine RJ, Wise RS. (1973). Effects of atropine, reserpine, 6-

hydroxydopamine and handling on seizure development in the rat. Exp. Neurol.,

40: 457-470.

Aroniadou-Anderjaska V, Fritsch B, Qashu F, Braga MF. (2008). Pathology and

pathophysiology of the amygdala in epileptogenesis and epilepsy. Epilepsy Res.,

78: 102-116.

Arriza JL, Eliasof S, Kavanaugh MP,  Amara SG. (1997). Excitatory amino

acidtransporter 5, a retinal glutamate  transporter coupled to a chloride

conductance. Proc. Natl. Acad. Sci. USA, 94: 4155-4160.

Arriza JL, Fairman WA, Wadiche JI, Murdoch GH, Kavanaugh MP, Amara SG.

(1994). Functional comparison of three  glutamate transporter subtypes cloned

from human motor cortex. J. Neurosci., 14: 5559-5569. References

Ashe J, Weimberger NM. (1991). Acetylcholine modulation of cellular excitability via

muscarinic receptors: functional plasticity in auditory cortex. In: Activation and

Acquisition: Functional Aspects of the Basal Forebrain Cholinergic System,

edited by R. T. Richardson. Boston: Birkha¨user. 189-246.

Babb TL, Brown WJ, Pretorius JK, Davenport C, Lieb JP, Crandall PH. (1984).

Temporal lobe volumetric cell densities in temporal lobe epilepsy.  Epilepsia,

25: 729-740.

Babb TL, Kupfer WR, Pretorius JK, Isokawa-Akesson M, Levesque MF. (1991).

Synaptic recurrent excitation of granule cells by mossy fibers in human

epileptic hippocampus. Neuroscience, 42: 351-363.

Babb TL, Pretorius JK, Kupfer WR, Crandall PH. (1989). Glutamate decarboxylase

immunoreactive neurons are preserved in human epileptic hippocampus.  J.

Neurosci., 9: 2562-2574.

Bagdy G, Kecskemeti V, Riba P, Jakus  R. (2006). Serotonin and epilepsy.  J.

Neurochem., 100: 857-873.

Baloh RW, Jacobson KM, Beykirch K, Honrubia V. (1998). Static and dynamic

posturography in patients with vestibular and cerebellar lesions. Arch. Neurol.,

55: 649-654.

Baltrons AM, Saadoun S, Agullo L, Garcia A. (1997). Regulation of calcium of the

nitric oxide/cyclic GMP system in cerebellar granule cells and astroglia in

culture. J.  Neurosci. Res., 49: 333-341.

Baraban SC, Hollopeter G, Erickson JC,  Schwartzkroin PA,  Palmiter RD. (1997).

Knock-out mice reveal a critical antiepileptic role for neuropeptide Y.  J.

Neurosci., 17: 8927-8936.

Baran H, Sperk G, Hortnagl H, Sapetschnig G, Hornykiewicz O. (1985). Alpha 2-

adrenoceptors modulate kainic  acid-induced limbic seizures.  Eur. J.

Pharmacol., 113: 263-269.

Barnes NM, Sharp T. (1999). A review of central 5-HT receptors and their function.

Neuropharmacology, 38: 1083-1152.

Bassant MH, Ennouri K, Lamour Y. (1990).  Effects of iotophoretically applied

monoamines on somatosensory cortical neurons of unanesthetized rats.

Neuroscience, 39: 431-439. Bausch SB, Chavkin C. (1997). Changes in hippocampal circuitry after

pilocarpineinduced seizures as revealed by opioid receptor distribution and

activation. J. Neuroscience., 17: 477-492.

Bausch SB, McNamara JO. (1999). Experimental partial epileptogenesis.

Curr.Opin.Neurol., 12: 203-209.

Beck SG, Choi KC. (1991). 5-Hydroxytryptamine hyperpolarizes CA3 hippocampal

pyramidal cells through an increase in potassium conductance. Neurosci. Lett.,

133: 93-96.

Behr J, Heinemann U. (1996). Effects of serotonin on differnt patterns of low Mg 2+

induced epileptiform activity in the subiculum of rats studied in vitro.  Brain

Res., 737: 331-334.

Ben-Ari Y. (1985). Limbic seizure and brain damage produced by kainic acid:

mechanisms and relevance to human temporal lobe epilepsy. Neuroscience, 14:

373-403.

Benquet P, Gee CE, Gerber U. (2002). Two distinct signaling pathways upregulate

NMDA receptor responses via two distinct metabotropic glutamate receptor

subtypes. J. Neurosci., 22: 9679-9686.

Berridge MJ, Galione A. (1988). Cytosolic calcium oscillators. FASEB J., 15: 3074-

3082.

Berridge MJ. (1993). Inositol trisphosphate and calcium signalling. Nature, 361:315-

325.

Bhattacharya SK, Ghosal S. (1998). Anxiolytic activity of a standardized extract of

Bacopa monniera: an experimental study. Phytomedicine, 5: 77-82.

Bhattacharya SK, Kumar A, Ghosal S. (1999). Effect of Bacopa monnieri on animal

models of Alzheimer’s disease and perturbed central cholinergic markers of

cognition in 

Bishnoi M, Chopra K, Shrinivas K, Kulkarni. (2008). Protective Effect of L-type

Calcium Channel Blockers Against Haloperidol-induced Orofacial Dyskinesia:

A Behavioural, Biochemical and Neurochemical Study. Neurochem. Res., 33:

1869-1880. References

Bjoras M, Gjesdal O, Erickson JD, Torp R, Levy LM, Ottersen OP, Degree M, StormMathisen J, Seeberg E, Danbolt NC. (1996). Cloning and expression of a

neuronal rat brain glutamate transporter. Mol. Brain Res., 36: 163-168.

Bjorklund A, Lindvall O. (1984). Dopamine-containing systems in the CNS.  In:

Handbook of Chemical Neuroanatomy:Classical Transmitter in the Rat, edited

by Bjorklund A and Hokfelt T. Amsterdam: Elsevier, 55-122.

Blair RE, Sombati S, Churn SB, Delorenzo RJ. (2008). Epileptogenesis causes an Nmethyl-d-aspartate receptor/Ca2+-dependent decrease in Ca2+/calmodulindependent protein kinase II activity in a hippocampal neuronal culture model of

spontaneous recurrent epileptiform discharges. Eur. J. Pharmacol., 588: 64-71.

Bleakman D, Rusin KI, Chard PS, Glaum SR, Miller RJ. (1992). Metabotropic

glutamate receptors potentiate ionotropic glutamate responses in the rat dorsal

horn. Mol. Pharmacol., 42: 192-196.

Bliss TVP, Goddard GV, Riives M. (1983). Reduction of long-term potentiation in the

dentate gyrus of the rat following selective depletion of monoamines.  J.

Physiol., 334: 475-491.

Blumer D, Montouris G, Davies K. (2004). The interictal dysphoric disorder:

recognition, pathogenesis, and treatment of the major psychiatric disorder of

epilepsy. Epilepsy Behav., 5: 826-840.

Bo T, Jiang Y, Cao H, Wang J, Wu X. (2004). Long term effecs of seizures in

neonatal rats on spatial learning ability and N-methyl-D-aspartate receptor

expression in the brain. Brain Res. Dev. Brain Res.152: 137-142.

Boehning D, Patterson RL, Sedaghat L, Glebova NO, Kurosaki T, Snyder SH. (2003).

Cytochrome c binds to inositol (1,4,5) trisphosphashate receptors, amplifying

calcium-dependant apoptosis. Nature Cell. Biol., 5: 1051-1061. 

Boess FG, Martin IL. (1994). Molecular biology of 5-HT receptors.

Neuropharmacology, 33: 275-317.

Bogdanski DF, Pletscher A, Brodie BB, Udenfriend S. (1956). Identification and

assay of serotonin in brain. J. Pharmacol. Exp. Ther., 117: 82-88.

Bonsi P, Cuomo D, De Persis C, Centonze D, Bernardi G, Calabresi P, Pisani A.

(2005). Modulatory action of metabotropic glutamate receptor (mGluR) 5 on mGluR1 function in striatal cholinergic interneurons. Neuropharmacology, 49:

104-113.

Bootman M, Niggli E, Berridge M, Lipp P. (1997). Imaging the hierarchical Ca2+

signalling system in HeLa cells. J.Physiol., 499: 307-314.

Bordi F, Ugolini A. (1999). Group I metabotropic glutamate receptors: implications

for brain diseases. Prog.Neurobiol., 59: 55-79.

Bothwell S, Meredith GE, Phillips J, Staunton H, Doherty C, Grigorenko E, Glazier S,

Deadwyler SA, O'Donovan CA, Farrell M. (2001). Neuronal hypertrophy in the

neocortex of patients with temporal lobe epilepsy. J. Neurosci., 21: 4789-4800.

Bradford HF. (1995). Glutamate, GABA and epilepsy. Prog. Neurobiol., 47: 477-511.

Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PPA, Middlemiss DN,

Mylecharane EJ, Richardson BP, Saxena PR. (1986). Proposals for the

classification and nomenclature of functional receptors for 5-

hydroxytryptamine. Neuropharmacology, 25: 563-576.

Bradshaw CM, Sheridan RD, Szabadi E.  (1985). Excitatory neuronal responses to

dopamine in the cerebral cortex: involvement of D2 but not D1 dopamine

receptors. Brit. J. Pharmacol., 86: 483-490.

Bredt DS, Snyder SH. (1990). Isolation of nitric oxide synthetase, a calmodulinrequiring enzyme. Proc. Natl. Acad. Sci. USA, 87: 682-685.

Brown I, Martin Smith M. (1960). Anticancer activity of Betulinic acid, a triterpine

from Bacopa monnieri. J. Chemi. Soc., 2783.

Brusa R, Zimmermann F, Koh DS, Feldmeyer D, Gass P, Seeburg PH, Sprengel R.

(1995). Early onset epilepsy and postnatal lethality associated with an editing

deficient GluRB allele in mice. Science, 270: 1677-1680.

Bunney BS, Aghajanian GK. (1976). Dopamine and norepinephrine innervated cells

in the rat prefrontal cortex: pharmacological differentiation using

microiontophoretic techniques. Life Sci., 19: 1783-1792.

Burns CM, Chu H, Rueter  SM, Hutchinson LK, Canton H, Sanders-Bush E, Emeson

RB. (1997). Regulation of Serotonin2C receptor G-protein coupling by RNA

editing. Nature, 387: 303-308. References

Calabrese C, Gregory WL, Leo M, Kraemer D, Bone K, Oken B. (2008). Effects of a

Standardized Bacopa monnieri Extract on Cognitive Performance, Anxiety, and

Depression in the Elderly: A Randomized, Double-Blind, Placebo-Controlled

Trial. J. Altern Complement Med., In press.

Campbell BM, Merchant KM. (2003). Serotonin2C

receptors within the basolateral

amygdala induces acute fear-like responses in an open-field environment. Brain

Res., 993: 1-9.

Canaves JM, Taylor SS. (2002).Classification and phylogenetic analysis of the cAMPdependent protein kinase regulatory subunit family. J Mol Evol., 54: 17-29.

Canton H, Emeson RB, Barker EL, Backstrom JR, Lu JT, Chang MS, Sanders-Bush

E. (1996). Identification, molecular cloning, and distribution of a short variant

of the 5- hydroxytryptamine2C receptor produced by alternative splicing. Mol.

Pharmacol., 50: 799-807.

Caramaschi D, de Boer SF, Koolhaas JM. (2007). Differential role of the 5-HT1A

receptor in aggressive and non-aggressive mice: an across-strain comparison.

Physiol. Behav., 90: 590-601.

Caramanos Z, Shapiro ML. (1994). Spatial memory and N-methyl-D-aspartate

receptor antagonists APV and MK-801: memory impairments depend on

familiarity with the environment, drug dose, and training duration. Behav

Neurosci. 108:30-43.

Carr DB, Cooper DC, Ulrich SL, Spruston ND, Surmeier J. (2002).  Serotonin

Receptor Activation Inhibits Sodium Current and  Dendritic Excitability in

Prefrontal Cortex via a Protein Kinase C-Dependent Mechanism. J. Neurosci.,

22: 6846-6855.

Castelli F, Frith C, Happe F, Frith U. (2002). Autism, Asperger syndrome and brain

mechanisms for the attribution of mental states to animated shapes. Brain, 125:

1839-1849.

Cavalheiro EA, Fernandes MJ, Turski L, Naffah-Mazzacoratti MG. (1994).

Spontaneous recurrent seizures in rats: amino acid and monoamine

determination in the hippocampus. Epilepsia, 35: 1-11.

Cavalheiro EA, Leite JP, Bortolotto ZA, Turski WA, Ikonomidou C, Turski L. (1991).

Long-term effects of pilocarpine in rats: structural damage of the brain triggers

kindling and spontaneous recurrent seizures. Epilepsia, 32: 778-782. Cavazos JE, Golarai G, Sutula TP. (1991). Mossy fiber synaptic reorganization

induced by kindling: time course of development, progression, and permanence.

J. Neurosci., 11: 2795-2803.

Ceci A, Brambilla A, Duranti P, Grauert M, Grippa N, Borsini F. (1999). Effect of

antipsychotic drugs and selective dopaminergic antagonists on

dopamineinduced facilitatory activity in  prelimbic cortical pyramidal neurons.

An in vitro study. Neuroscience, 93: 107-115.

Cendelín J, Korelusová I, Vozeh F. (2008). The effect of repeated rotarod training on

motor skills and spatial learning ability in Lurcher mutant mice. Behav. Brain

Res., 189: 65-74.

Cendes F. (2002). Febrile seizures and mesial temporal sclerosis. Curr. Opin. Neurol.,

17: 161-164.

Cepeda C, Li Z, Cromwell HC, Altemus KL, Crawford CA, Nansen EA, Ariano MA,

Sibley DR, Peacock WJ, Mathern GW, Levine MS. (1999).

Electrophysiological and morphological analyses of cortical neurons obtained

from children with catastrophic epilepsy: dopamine receptor modulation of

glutamatergic responses. Dev. Neurosci., 21: 223-235.

Cerne R, Randic M. (1992). Modulation of AMPA and NMDA responses in rat spinal

dorsal horn neurons by trans-1-aminocyclopentane- 1,3-dicarboxylic acid.

Neurosci. Lett., 144: 180-184.

Chakravarty AK, Garai Masuda K,  Nakane T, Kawahara N. (2003).  Chem. Phar.

Bull., 51: 215-217.

Chalmers M, Schell MJ, Thorn P. (2006). Agonist-evoked inositol trisphophate

receptor (IP3R) clustering is not dependent on changes in the structure of the

endoplasmic reticulum. Biochem.J., 394: 57-66.

Chan-Palay V. (1976). Serotonin axons in the supra- and subependymal plexuses and

in the leptomeninges: Their roles in local alterations of cerebrospinal fluid and

vasomotor activity. Brain Res., 102: 103-130.

Charriaut-Marlangue C, Ben-Ari Y. (1995). A cautionary note on the use of the

TUNEL stain to determine apoptosis. Neuroreport., 7: 61-64.

Chen G, Ensor GR, Bohner B. (1954). A facilitation action of reserpine on the central

nervous system. Proc. Soc. Exp. Biol. Med., 86: 507-510. References

Chen S, Huang X, Zeng XJ, Sieghart W, Tietz EI. (1999). Benzodiazepine-mediated

regulation of alpha1, alpha2, beta1–3 and gamma2 GABA(A) receptor subunit

proteins in the rat brain hippocampus and cortex. Neuroscience, 93: 33-44.

Chen S, Kobayashi M, Honda Y, Kakuta S, Sato F, Kishi K. (2007). Preferential

neuron loss in rat piriform cortex following pilocarpine induced status

epilepticus. Epilepsy Res., 74: 1-18.

Cheng Y, Prusoff WH. (1973). Relationship between the inhibition constant (K1) and

the concentration of inhibitor which causes 50 per cent inhibition (I50) of an

enzymatic reaction. Biochem. Pharmacol., 22: 3099-3108.

Chetkovich DM, Sweatt JD. (1993). NMDA receptor activation increases cyclic AMP

in area CA1 of the hippocampus via calcium/calmodulin stimulation of adenylyl

cyclase. J.Neurochem., 61: 1933-1942.

Choi DS, Maroteaux L. (1996). Immunohistochemical localisation of the serotonin 5-

HT2B receptor in mouse gut, cardiovascular system, and brain. FEBS Lett., 391:

45-51.

Choi DW. (1988). Glutamate neurotoxicity and diseases of the nervous system.

Neuron, 1: 623-634.

Chu Z, Hablitz JJ. (2000). Quisqualate induces an inward current via mGluR

activation in neocortical pyramidal neurons. Brain Res., 879: 88-92.

Clarke WP, Yocca FD, Maayani S. (1996). Lack of 5-hydrotrytamine 1A- mediated

inhibition of adenylyl cyclase in dorsal raphe of male and female rats.  J.

Pharmacol Exp Ther., 277: 1259-1266.

Clifford DB, Olney JW, Maniotis A, Collins RC, Zorumski CF. (1987). The

functional anatomy and pathology of lithium-pilocarpine and high-dose

pilocarpine seizures. Neuroscience, 23: 953-968.

Clinkers R, Gheuens S, Smolders I, Meurs A, Ebinger G, Michotte Y. (2005). In vivo

modulatory action of extracellular glutamate on the anticonvulsant effects of

hippocampal dopamine and serotonin. Epilepsia, 46: 828-836.

Cohen, Pitkänen A, Lukasiuk K. (2009). Molecular and cellular basis of

epileptogenesis in symptomatic epilepsy. Epilepsy Behav., 14 Suppl 1: 16-25.

Collingridge GL, Bliss TVP. (1987). NMDA  receptors-their role in long-term

potentiation. Trends Neurosci., 10: 288-293.

Collins JR (1994) Seizures and other neurologic manifestation of allergy. Vet. Clin.

North Ann. Small Aim Pract. 24: 735- 748.

Conn PJ, Pin JP. (1997). Pharmacology  and function of metabotropic glutamate

receptors. Annu.Rev.Pharmacol.Toxicol., 37: 205-237.

Conn PJ, Saunders-Bush E. (1987). Relative efficacies of piperazines at the

phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5- HT-1c)

receptors. J. Pharmacol. Exp. Ther., 242: 552-557.

Conti F, Weinberg RJ. (1999). Shaping excitation at glutamatergic synapses. Trends

Neurosci., 22: 451-458.

Conti F, DeBiasi S, Minelli A, Rothstein JD, Melone M. (1998).  EAAC1, a highaffinity glutamate tranporter, is localized to astrocytes and gabaergic neurons

besides pyramidal cells in the rat cerebral cortex. Cereb Cortex. 8: 108-116.

Corlew R, Brasier DJ, Feldman DE, Philpot BD. (2008). Presynaptic NMDA

receptors: newly appreciated roles in cortical synaptic function and plasticity.

Neuroscientist, 6: 609-625.

Coulter DA, Rafiq A, Shumate M, Gong QZ, DeLorenzo RJ, Lyeth BG. (1996). Brain

injury induced enhanced limbic epileptogenesis: anatomical and physiological

parallels to an animal model of temporal lobe epilepsy. Epilepsy Res., 26: 81-

91.

Covolan L, Mello LE. (2006). Assessment of the progressive nature of cell damage in

the pilocarpine model of epilepsy. Braz. J. Med. Biol. Res., 39: 915-924.

Crawley JN. (2007). What's Wrong With My Mouse? Behavioral phenotyping of 

transgenic and knockout mice, second edition. (John Wiley & Sons, New York).

Cronin J, Obenaus A, Houser CR, Dudek FE. (1992). Electrophysiology of dentate

granule cells after kainate-induced synaptic reorganization of mossy fibers.

Brain Res., 573: 305-310.

Cryan JF, Holmes A. (2005). The ascent of mouse: advances in modelling human

depression and anxiety. Nat. Rev. Drug Discov., 4: 775-790. References

Cumming-Hood PA, Strahlendorf HK, Strahlendorf C. (1993). Effects of serotonin

and the 5-HT2C/1C

receptor agonist. DOl on neurons of the cerebellar

dentate/interpositus nuclei: possible involvement of a GABAergic interneuron.

Eur. J. Pharmaco., 236: 457-465.

Dailey JW, Jobe PC. (1986). Indices of noradrenergic function in the central nervous

system of seizure-naive genetically epilepsy-prone rats. Epilepsia., 27: 665-670.

Dailey JW, Reigel CE, Mishra PK, Jobe PC. (1989). Neurobiology of seizure

predisposition in the genetically epilepsy-prone rat. Epilepsy Res., 3: 317-320.

Dailey JW, Reith ME, Yan QS, Li MY, Jobe PC. (1997). Anticonvulsant doses of

carbamazepine increase hippocampal extracellular serotonin in genetically

epilepsy-prone rats: Dose response relationships. Neurosci. Lett., 227: 13-16.

Danbolt NC, Storm-Mathisen J, Kanner BI. (1992). A [Na1/K1]coupled Lglutamate

transporter purified from rat brain is located in glial cell processes.

Neuroscience, 51: 259-310.

Danbolt NC. (2001). Glutamate uptake. Prog. Neurobiol., 65: 1-105.

Das VA, Finla C, Paulose CS. (2006). Decreased α2 -adrenergic receptor in the brain

stem and pancreatic islets during pancreatic regeneration in weanling rats. Life

Sci., 79: 1507-1513.

Das A, Shanker G, Nath C, Pal R, Singh S, Singh H. (2002). A comparative study in

rodents of standardized extracts of  Bacopa monnieri  and Ginkgo biloba.

Pharmacol.

Dawson T, Wamseley J. (1983). Autoradiographic localization of [

3

H]imipramine

binding sites: Association with serotonergic neurons. Brain Res. Bull., 11: 325-

334.

De Camilli P, Miller PE, Levitt P, Walter U, Greengard P. (1984). Anatomy of

cerebellar Purkinje cells in the rat determined by a specific

immunohistochemical marker. Neuroscience, 11: 761-817.

De Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, Bos

JL. (1998). Epac is a Rap1 guanine-nucleotide-exchange factor directly

activated by cyclic AMP. Nature, 396: 474-477. De Sarro G, Di Paola ED, De Sarro A, Vidai MJ. (1993). L-Arginine potentiates

excitatory amino acid-induced seizures elicited in the deep prepiriform cortex.

Eur. J. Pharmacol., 230: 151-158.

De Sousa FC, Leite CP, de Melo CT, de Araújo FL, Gutierrez SJ, Barbosa-Filho JM,

Fonteles MM, de Vasconcelos, SM, de Barros Viana GS. (2007). Evaluation of

effects of N-(2-hydroxybenzoyl) tyramine (riparin II) from Aniba riparia

(NEES) MEZ (Lauracea) in anxiety models in mice.  Biol. Pharm. Bull., 30:

1212-1216.

De Vente J, Asan E, Gambaryan S, Markerink-van Ittersum M, Axer H, Gallatz K,

Lohmann SM, Palkovits M. (2001). Localization of cGMP-dependent protein

kinase type II in rat brain. Neuroscience, 108: 27-49.

Deacon TW, Eichenbaum H, Rosenberg P, Eckmann KW. (1983). Afferent

connections of the perirhinal cortex in the rat. J. Comp. Neurol., 220: 168-190.

Deepak M, Amit A. (2004). The need for establishing identities of 'bacoside A and B',

the putative major bioactive saponins of Indian medicinal plant  Bacopa

monnieri. Phytomedicine, 11: 264-268.

Degiorgio CM, Tomiyasu U, Gott PS, Treiman DM. (1992). Hippocampal pyramidal

cell loss in human status epilepticus. Epilepsia, 33: 23-27.

Dekeyne A, Mannoury la Cour C, Gobert A, Brocco M, Lejeune F, Serres F, Sharp T,

Daszuta A, Soumier A, Papp M, Rivet JM, Flik G, Cremers TI, Muller O,

Lavielle G, Millan MJ.  (2008). S32006, a novel 5-HT2C receptor antagonist

displaying broad- based antidepressant and anxiolytic properties in rodent

models. Psychopharmacology, 199: 549-568.

Delgado PL. (2004). Common pathways of depression and pain. J. Clin. Psychiatry,

65: S16-S19.

Descarries L, Beaudet A, Watkins K. (1975). Serotonin nerve terminals in adult rat

neocortex. Brain Res., 100: 563-588.

Devinsky O. (2004). Diagnosis and treatment of temporal lobe epilepsy. Rev. Neurol.

Dis., 1: 2-9.

Dhawan BN, Singh HK. (1996). Pharmacological studies on  Bacopa monniera, an

Ayurvedic nootropic agent.  European Journal of Neuropsychopharmacology,

653: 144-149. References

Dieudonné S, Dumoulin A. (2000). Serotonin-Driven Long-Range Inhibitory

Connections in the Cerebellar Cortex. Journal of Neurosci., 20: 1837-1848.

Di Giovanni G, Di Matteo V, Pierucci M, Benigno A, Esposito E. (2006). Central

serotonin2C receptor: from physiology to pathology. Curr.Topics Med.Chem., 6:

1909-1925.

Dichter MA. (1994). Emerging insights into mechanisms of epilepsy: implications for

new antiepileptic drug development. Epilepsia., 35: 51-57.

Dickson CT, Alonso A. (1997). Muscarinic induction of synchronous population

activity in the entorhinal cortex. J. Neurosci., 17: 6729-6744.

Dickson CT, Kirk IJ, Oddie SD, Bland BH. (1995). Classification of theta-related

cells in the entorhinal cortex: cell  discharges are controlled by the ascending

brainstem synchronizing pathway in parallel with hippocampal theta-related

cells. Hippocampus, 5: 306-319.

Diener H, Dichgans J, Guschlbauer B, Bacher M, Langenbach P. (1989). Disturbances

of motor preparation in basal ganglia and cerebellar disorders. Prog. Brain Res.,

80: 481-488.

Ding D, Hong Z, Wang WZ, Wu JZ, de Boer HM, Prilipko L, Sander JW. (2006).

Assessing the disease burden due to epilepsy by disability adjusted life year in

rural China. Epilepsia, 47: 2032-2037.

Dingledine R, Borges K, Bowie D, Traynelis SF. (1999). The glutamate receptor ion

channels. Pharmacol. Rev., 51: 07-61.

Dremier S, Pohl V, Poteet-Smith C, Roger PP, Corbin J, Doskeland SO, Dumont JE,

Maenhaut C. (1997). Activation of cyclic AMP-dependent kinase is required but

may not be sufficient to mimic cyclic AMP-dependent DNA synthesis and

thyroglobulin expression in dog thyroid cells. Mol. Cell Biol., 11: 6717-6726.

Duan YHL, Wu CM, Shen CL. (1989). Distribution of serotonin immunoreactive

neurons in the brainstem of the hamster, guinea pig, rabbit and rat. Proc. Natl.

Sci. Conc. Repub. China B, 13: 218-219.

Dunham NW, Miya TS. (1957). A Note on a Simple Apparatus for Detecting

Neurological Deficit in Rats & Mice. J. Am. Pharmaceut. Assoc. Scientific Edit,

XLVI: No. 3. Dunnett S, Fibiger HC. (1993). Role of forebrain cholinergic systems in learning and

memory: relevance to the cognitive deficits of aging and Alzheimer’s dementia.

Prog. Brain Res., 98: 413-420.

Durstewitz D, Seamans JK, Sejnowski TJ. (2000). Dopamine-mediated stabilization

of delay-period activity in a network model of prefrontal cortex.  J.

Neurophysiol., 83: 1733-1750.

Dutton AC, Barnes NM. (2006). Anti-obesity pharmacotherapy: future  perspectives

utilising 5-HT2C receptor agonists. Drug Disc Today: Therapeutic Strategies, 3:

577-583.

Ekonomou A, Angelatou F. (1999). Upregulation of NMDA receptors in hippocampus

and cortex in the pentylenetetrazol-induced ‘‘kindling’’ model of epilepsy.

Neurochem. Res., 24: 1515-1522.

Elangovan V, Govindasamy S, Ramamoorthy N, Balasubramanian K. (1995). In vitro

studies on the anticancer activity of Bacopa monnieri. Fitoterapia, 11: 66-211.

Endoh T. (2004). Characterization of modulatory effects of postsynaptic metabotropic

glutamate receptors on calcium currents in rat nucleus tractus solitarius. Brain

Res., 1024: 212-224.

Engel J. Jr. (1996). Introduction to temporal lobe epilepsy. Epilepsy Res., 26: 141-150.

Engel J. Jr. (2001). Intractable epilepsy: definition and neurobiology. Epilepsia, 42

Suppl. (6), 3.

Erecińska M, Silver IA. (1992). Relationship  between ions and energy metabolism:

cerebral calcium movements during ischemia and subsequent recovery. Can. J.

Physiol. Pharmacol., 70: 190-193.

Erickson JC, Clegg KE, Palmiter RD. (1996). Sensitivity to leptin and susceptibility to

seizures of mice lacking neuropeptide Y. Nature, 381: 415-421.

Erlander MG, Lovenberg TW, Baron BM, De Lecea L, Danielson PE, Racke M,

Slone AL, Siegel BW, Foye PE, Cannon K. (1993). Two members of a distinct

subfamily of 5-hydroxytryptamine receptors differentially expressed in rat

brain. Proc. Natl. Acad. Sci., 90: 3452-3456.

Ernst E. (2006). Herbal remedies for anxiety - a systematic review of controlled

clinical trials. Phytomedicine. 13: 205-208. References

Eskandari S, Kreman M, Kavanaugh MP, Wright EM, Zampighi GA. (2000).

Pentameric assembly of a neuronal glutamate transporter. Proc Natl Acad Sci. U

S A. 97:8641-8646.

Esclapez M, Hirsch JC, Ben-Ari Y,  Bernard C. (1999). Newly formed excitatory

pathways provide a substrate for hyperexcitability in experimental temporal

lobe epilepsy. J. Comp. Neurol., 408: 449-460.

Faingold CL (1999). Neurons in the deep layers of superior colliculus play a critical

role in the neuronal network for audiogenic seizures: mechanisms for

production of wild running behavior. Brain Res., 815: 250-258.

Fairman WA, Vandenberg RJ, Arriza JL, Kavanaugh MP, Amara SG. (1995). An

excitatory amino-acid transporter with  properties of a ligand-gated chloride

channel. Nature, 375: 599-603.

Feldman S. and Weidenfeld J. (1998). The excitatory effect of amygdala on

hypothalamo pituitary adrenocortical responses are mediated by hypothalamic

norepinephrine, serotonin, and CRF-41. Brain Research Bulletin, 45: 389-93.

Ferron A, Thierry AM, LeDouarin C, Glowinski J. (1984). Inhibitory influence of the

mesocortical dopaminergic system on  spontaneous activity or excitatory

response induced from the thalamic mediodorsal nucleus in the rat medial

prefrontal cortex. Brain Res., 302: 257-265.

Fiscus RR, Rapoport RM, Waldman SA, Murad F. (1985). Atriopeptin II elevates

cyclic GMP, activates cyclic GMP-dependent protein kinase and causes

relaxation in rat thoracic aorta. Biochem.Biophys.Acta., 846: 179-184.

Fisher PD, Sperber EF, Moshe SL. (1998). Hippocampal sclerosis revisited.  Brain

Dev., 20: 563-573.

Fletcher A, Forster EA. (1988). A proconvulsant action of selective a2-adrenoceptor

antagonists. Eur. J. Pharmacol., 151: 27-34.

Fone KC, Shalders K, Fox ZD, Arthur R, Marsden CA. (1996). Increased 5-HT2C

receptor responsiveness occurs on rearing rats in social isolation.

Psychopharmacology, 123: 346-352. Fone KCF, Austin RH, Topham IA, Kennett GA, Punhani T. (1998). Effect of chronic

m-CPP on locomotion, hypophagia, plasma corticosterone and 5-HT2C receptor

levels in the rat. Br. J. Pharmacol., 123: 1707-1715.

Fone KCF, Shalders K, Fox ZD, Arthur R, Marsden CA. (1996). Increased 5-HT2C

receptor responsiveness occurs on rearing rats in social isolation.

Psychopharmacologia, 23: 346-352.

Freitas RM, Sousa FC, Viana GS, Fonteles MM. (2006). Effect of gabaergic,

glutamatergic, antipsychotic and antidepressant drugs on pilocarpine-induced

seizures and status epilepticus. Neurosci.Lett., 408: 79-83.

Frotscher M, Zimmer J. (1983). Lesion-induced mossy fibers to the molecular layer of

the rat fascia dentata: identification of postsynaptic granule cells by the GolgiEM technique. J Comp Neurol, 215 :  299-311.

Fujii S, Sasaki H, Mikoshiba K, Kuroda Y, Yamazaki Y, Mostafa Taufiq A, Kato H.

(2004). A chemical LTP induced by co-activation of metabotropic and Nmethyl-D-aspartate glutamate receptors in hippocampal CA1 neurons.  Brain

Res., 999: 20-28.

Funahashi S, Bruce CJ, Goldman-Rakic PS.(1989). Mnemonic coding of visual space

in the monkey's dorsolateral prefrontal cortex. J. Neurophysiol., 61: 331-349.

Fuxe K, Calza L, Benfenati F, Zini I, Agnatti L. (1983). Quantitative autoradiographic

localization of [3H]imipramine binding sites in the brain of the rat. Relationship

to ascending 5-hydroxytryptamine neuron systems. Proc. Natl. Acad. Sci. USA,

80: 3836-3840.

Gall CM, lsackson PJ. (1989). Limbic seizures increase neuronal production of

messenger RNA for nerve growth factor. Science, 245: 758-761.

Galván EJ, Calixto E, Barrionuevo G. (2008). Bidirectional Hebbian plasticity at

hippocampal mossy fiber synapses on CA3 interneurons.  J.Neurosci., 28:

14042-55.

Garthwaite J. (1991). Glutamate, nitric  oxide and cell-cell signaling in the nervous

system. Trends Neurosci., 14: 60-67.

Garthwaite J. (2005). Dynamics of cellular NO-cGMP signaling. Front. Biosci., 10:

1868-1880. References

Gastens Alexandra M, Brandt Claudia,  Bankstahl JP, Löscher Wolfgang. (2008).

Predictors of pharmacoresistant epilepsy: Pharmacoresistant rats differ from

pharmacoresponsive rats in behavioral  and cognitive abnormalities associated

with experimentally induced epilepsy. Epilepsia, 49: 1759-1776.

Gaykema RPA, Luiten PGM, Nyakas C, Traber J. (1990). Cortical projection patterns

of the medial septum-diagonal band complex. J. Comp. Neurol., 293: 103-124.

Geijo-Barrientos E, Pastore C. (1995). The effects of dopamine on the sub threshold

electrophysiological responses of rat prefrontal cortex neurons in vitro. Eur. J.

Neurosci., 7: 358-366.

George B, Kulkarni SK. (1997). Modulation of lithium-pilocarpine-induced status

epilepticus by adenosinergic agents. Methods Find Exp. Clin. Pharmacol., 19:

329-333.

Giorgetti M, Tecott LH. (2004). Contributions of 5-HT2C receptors to multiple actions

of central serotonin systems. Eur. J. Pharmacol., 488: 1-9.

Glowinski J, Iversen LL. (1966). Regional studies of catecholamines in the rat brain:

The disposition of [3H] Norepinephrine, [3H] DOPA in various regions of the

brain. J. Neurochem., 13: 655-669.

Gobert A, Rivet J, Lejeune F, Newman-Tancredi A, Adhumeau-Auclair A, Nicolas

JP. (2000). Serotonin(2C) receptors tonically suppress the activity of

mesocortical dopaminergic and adrenergic, but not serotonergic pathways, a

combined dialysis and electrophysiological analysis in the rat. Synapse, 36: 205-

221.

Gold PW. (2005). The neurobiology of stress and its relevance to psychotherapy.

Clinical Neuroscience Research, 4: 315–324.

Gonzalez MI, Ortega A. (2000). Regulation of high-affinity glutamate uptake activity

in Bergmann glia cells by glutamate. Brain Res., 866: 73-81.

Gonzalez-Burgos G, Kroner S, Krimer LS, Seamans JK, Urban NN, Henze DA,

Lewis DA, Barrionuevo G. (2002). Dopamine modulation of neuronal function

in the monkey prefrontal cortex. Physiol. Behav., 77: 537-543.

Gonzalez-Islas C, Hablitz JJ. (2003).  Dopamine enhances EPSCs in layer II-III

pyramidal neurons in rat prefrontal cortex. J. Neurosci., 23: 867-875. Gorelova N, Yang CR. (2000). Dopamine  D1/D5 receptor activation modulates a

persistent sodium current in rat prefrontal cortical neurons  in vitro.  J.

Neurophysiol., 84: 75-87.

Goulding EH, Ngai J, Kramer RH, Colicos S, Axel R, Siegelbaum SA, Chess, A.

(1992). Molecular cloning and single-channel properties of the cyclic

nucleotide-gated channel from catfish olfactory neurons. Neuron, 8: 45-58.

Gowen E, Miall C. (2005). Behavioural aspects of cerebellar function in adults with

Asperger syndrome. The Cerebellum, 4: 1-11.

Grailhe R, Amlaiky AN, Ghavami A, Ramboz S, Yocca F, Mahle C, Margouris C,

Perrot F, Hen R. (1994). Human and mouse 5-HT5A and 5-HT5B receptors:

Cloning and functional expression. Soc. Neurosci. Abstr., 20: 1160.

Graumlich, JF, Mc Laughlin RG, Birkhahn D, Shah N, Jobe, PC, Dailey JW. (1999).

Carbamazepine pharmacokinetics-pharmacodynamics in genetically epilepsyprone rats. Eur. J. Pharmacol., 369: 305-311.

Grigorenko E, Glazier S, Bell W, Tytell M, Nosel E, Pons T, Deadwyler SA. (1997).

Changes in glutamate receptor subunit composition in hippocampus and cortex

in patients with refractory epilepsy. J. Neurol. Sci., 153: 35-45.

Gulledge AT, Jaffe DB. (2001). Multiple effects of dopamine on layer V pyramidal

cell excitability in rat prefrontal cortex. J. Neurophysiol., 86: 586-595.

Gurevich I, Tamir H, Arango V, Dwork AJ, Mann JJ, Schmauss G. (2002). Altered

editing of Serotonin 2C receptor pre-mRNA in the prefrontal cortex of

depressed suicide victims. Neuron, 34: 349-356.

Guzman HDP, Inaba Y, Baldelli E, de Curtis M, Biagini G, Avoli M. (2008). Network

hyperexcitability within the deep layers  of pilocarpine-treated rat entorhinal

cortex. J Physiol., 586:1867-83.

Hackler EA, Turner GH, Gresch PJ, Sengupta S, Deutch AY, Avison MJ, Gore JC,

Sanders-Bush E. (2007). 5-Hydroxytryptamine2C receptor contribution to mchlorophenylpiperazine and N-methylb- carboline-3-carboxamide-induced

anxiety-like behavior and limbic brain activation.  J. Pharm. Exp. Ther., 320:

1023-1029.

Hagan JJ, Hatcher JP, Slade PD. (1995). The role of 5-HT1D and 5-HT1A receptors

in mediating 5-hydroxytryptophan induced myoclonic jerks in guinea pigs. Eur. References

J. Pharmacol., 294: 743-751.

Hajnal A, Lenard L, Czurko A, Sandor P, Karadi Z. (1997). Distribution and time

course of appearance of ‘dark’ neurons and EEG activity after amygdaloid

kainate lesion. Brain Res. Bull., 433: 235-243.

Hajszan T, MacLusky NJ. (2006). Neurologic links between epilepsy and depression

in women: is hippocampal neuroplasticity the key? Neurology, 66: S13-S22.

Hamon M, Bourgoin S, el Mestikawy S, Goetz C. (1982). Central serotonin receptors.

Oxford: Blackwell Science: 107-143.

Hardman JG, Goodman Gilman A, Limbird LE. (1996). Goodman & Gilman’s The

Pharmacological Basis of Therapeutics. New York, New York: McGraw- Hill,

237-365.

Harvey AS, Berkovic SF, Wrennall JA, Hopkins IJ. (1997). Temporal lobe epilepsy in

childhood: clinical, EEG, and neuroimaging findings and syndrome

classification in a cohort with new-onset seizures. Neurology, 49: 960-968.

Hashimoto Y, Araki H, Gomita Y. (2004). Cessation of repeated administration of

MK-801 changes the anticonvulsant effect against flurothyl-induced seizure in

mice. Pharmacol. Biochem. Behav., 74: 909-915.

Hauser WA. (1997). Incidence and prevalence. In: Engel JJr, Pedley TA (eds).

Epilepsy – A Comprehensive Textbook.  Lippincott-Raven Publishers,

Philadephia, 47-58.

Heffner TG, Hartman JA, Seiden LS. (1980). A rapid method for the regional

dissection of the rat brain. Pharmacol. Biochem. Behav., 13: 453-456.

Heiser LK, Chu HM, Tecott LH. (1998). Epilepsy and obesity in serotonin 5-HT2C

receptor mutant mice. Ann. N.Y. Acad. Sci., 861: 74-78.

Hellier JL, White A, Williams PA, Edward Dudek F, Staley KJ. (2009). NMDA

receptor-mediated long-term alterations in epileptiform activity in experimental

chronic epilepsy. Neuropharmacology, In press.

Henze DA, Lewis DA, Barrionuevo G. (2002). Dopamine modulation of neuronal

function in the monkey prefrontal cortex. Physiol. Behav., 77: 537-543. Hernandez EJ, Willams PA, Dudek FE. (2002). Effect of fluoxetine and TFMPP on

spontaneous seizures in rats with pilocarpine induced epilepsy. Epilepsia., 43:

1337-1345.

Herrick-Davis K, Grinde E, Niswender CM. (1999). Serotonin 5-HT2C receptor RNA

editing alters receptor basal activity: implications for serotonergic signal

transduction. J. Neurochem., 73: 1711-1717.

Hertz L, Dringen R, Schousboe A, Robinson SR. (1999). Astrocytes: glutamate

producers for neurons. J. Neurosci. Res., 57: 417-428.

Heslop KE, Curzon G. (1999). Effect of reserpine on behavioural responses to

agonists at 5-HT1A, 5-HT1B, 5-HT2A, and 5-HT2C receptor subtypes.

Neuropharmacology, 38: 883-891.

Ho BC, Mola C, Andreasen NC. (2004). Cerebellar dysfunction in neuroleptic naive

schizophrenia patients: Clinical, cognitive, and neuroanatomic correlates of

cerebellar neurologic signs. Biol. Psychiatry, 55: 1146-1153.

Hoffman DJ, Zanelli SA, Kubin JM, Om P, Delivoria-P, Maria. (1996). The in vivo

Effect of Bilirubin on theN-Methyl-D-Aspartate Receptor/Ion Channel

Complex in the Brains of Newborn Piglets. Ped. Res., 40: 804-808.

Holmes A, Rodgers RJ. (1998). Responses of Swiss-Webster mice to repeated plusmaze experience: further evidence for  a qualitative shift in emotional state?

Pharmacol. Biochem. Behav., 60: 473-488.

Holmes GL. (2006). Clinical evidence that  epilepsy is a progressive disorder with

special emphasis on epilepsy syndromes that do progress.  Adv. Neurol., 97:

323-331.

Holmes KH, Keele NB, Shinnick-Gallagher P. (1996). Loss of mGluR-mediated

hyperpolarizations and increase in mGluR depolarizations in basolateral

amygdala neurons in kindling-induced epilepsy.  J. Neurophysiol., 76: 2808-

2812.

Holmes MD, Silbergeld DL, Drouhard D,Wilensky AJ, Ojemann LM. (2004). Effect

of vagus nerve stimulation on adults with pharmacoresistant generalized

epilepsy syndromes. Seizure, 13: 340-345. References

Holopainen I, Louve M, Enkvist MO, Akerman KE. (1989). 86Rubidium release from

cultured primary astrocytes: effects of  excitatory and inhibitory amino acids.

Neuroscience. 30:223-229.

Holopainen I, Louve M, Enkvist MOK, Akerman KEO. (1990). Coupling of

glutamatergic receptors to changes in intracellular Ca2+ in rat cerebellar granule

cells in primary culture. J. Neurosci. Res., 25: 187-193.

(Contd.)